Point72 (DIFC) Ltd
- SEC CIK
- 0002017863
- Latest filing
- Nov 14, 2025
RARE holding history
Ultragenyx Pharmaceutical Inc. in every 13F filed by Point72 (DIFC) Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RARE overviewAll 13F holders of RAREFull Q3 2025 holdings
- Shares (Q3 2025)
- 3,367
- Value
- $101.3K
- % of portfolio
- <0.1%
- Quarters held
- 7
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 3,367 | $101.3K | <0.1% | +1,191+54.7% | Added | Holders |
| Q2 2025 | 2,176 | $79.1K | <0.1% | −19,269−89.9% | Reduced | Holders |
| Q1 2025 | 21,445 | $776.5K | 0.1% | +2,825+15.2% | Added | Holders |
| Q4 2024 | 18,620 | $783.4K | 0.1% | +4,103+28.3% | Added | Holders |
| Q3 2024 | 14,517 | $806.4K | 0.1% | +11,848+443.9% | Added | Holders |
| Q2 2024 | 2,669 | $109.7K | <0.1% | −7,383−73.4% | Reduced | Holders |
| Q1 2024 | 10,052 | $469.3K | <0.1% | – | No prior filing | Holders |